BFNH

$6.85-1.08%visit website

BIOFORCE NANOSCIENCES HOLDINGS, INC.

Market Cap

$230M

Live price × SEC shares (Aug 10, 2026)

Sector

Health Care

Industry

Laboratory Analytical Instruments

Beta (raw)

0.79

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

99.8

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Total operating expenses	116	118	118	262	614
Operating income	(116)
Pretax income			(118)	(262)
Net income	(116)	(119)	(102)	239	(98)
EPS (basic) ($)	0.00		0.00	0.01	(0.01)
EPS (diluted) ($)	0.00		0.00	0.01	(0.01)
Weighted avg. shares (basic)	33,522		33,522	33,544
Weighted avg. shares (diluted)	33,522		33,522	33,544

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 10, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 32 more quarters, back to Sep 2017, with Tormere Pro.

Corporate Events (8-K)

7 filings in 12 months · 1 with priority itemsFull history →

Filed	Items	Filing
Oct 7, 2026 accepted 3:35 PM ET	8.01Other events	Document SEC ↗
Sep 4, 2026 accepted 4:51 PM ET	3.02Unregistered equity sale	Document SEC ↗
Aug 18, 2026 accepted 6:02 PM ET	7.01Reg FD disclosure	Document SEC ↗
Aug 14, 2026 accepted 7:23 PM ET	8.01Other events	Document SEC ↗
Jul 7, 2026 accepted 5:04 PM ET	8.01Other events	Document SEC ↗
Jul 1, 2026 accepted 1:15 PM ET	8.01Other events	Document SEC ↗
Jun 18, 2026 accepted 12:28 PM ET	5.01Change in control5.02Officer / director change8.01Other events	Document SEC ↗